The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors

Sadeleştirilmiş öğe sayfası
dc.contributor.authorEkemen, Suheyla
dc.contributor.authorBilir, Ebru
dc.contributor.authorSoultan, Hagar Elsayed Akram
dc.contributor.authorZafar, Sadia
dc.contributor.authorDemir, Figen
dc.contributor.authorTabandeh, Babek
dc.contributor.authorToprak, Sadik
dc.contributor.authorYapicier, Ozlem
dc.contributor.authorCoban, Cevayir
dc.date.accessioned2025-10-16T15:14:00Z
dc.date.issued2024
dc.identifier.doi10.2147/BCTT.S444077
dc.identifier.otherWOS:001141493400001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6027
dc.publisherDOVE MEDICAL PRESS LTD
dc.sourceBREAST CANCER-TARGETS AND THERAPY
dc.subjectbreast cancer
dc.subjectimmunotherapy
dc.subjectPD\\-L1
dc.subjectLCN2
dc.subjecttriple\\-negative breast cancer
dc.subjectTNBC
dc.titleThe Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS